site logo

Dexcom takes another step to keep CGMs in hospitals while Abbott targets athletes

COVID-19 hasn't stymied, and has in some cases spurred, the diabetes device makers' progress toward new populations for their glucose monitoring platforms.

Courtesy of Abbott